<DOC>
	<DOCNO>NCT00353262</DOCNO>
	<brief_summary>This single arm study investigate possible pharmacokinetic interaction Xeloda oxaliplatin , ass whether pharmacokinetics Xeloda and/or oxaliplatin influenced addition Avastin . All subject provide sample pharmacokinetic analysis first 3 cycle treatment . In cycle 1 2 patient receive treatment regimen contain Xeloda ( 1000mg/m2 bid ) oxaliplatin ( 130mg/m2 iv ) cycle 3 Avastin ( 7.5mg/kg iv ) add regimen . The anticipated time study treatment 3-12 month , target sample size &lt; 100 individual .</brief_summary>
	<brief_title>A Study Xeloda ( Capecitabine ) Combination With Oxaliplatin Patients With Metastatic Colorectal Cancer .</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>adult patient , &gt; =18 year age ; adenocarcinoma colon rectum , metastatic locally advanced disease . previous systemic treatment advance metastatic disease ; previous treatment oxaliplatin Avastin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>